|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.070 CNY | -5.76% |
|
-0.20% | -31.21% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.21B 766M 671M 619M 579M 1.09B 72.23B 1.11B 7.44B 2.88B 35.7B 2.88B 2.81B 124B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.07B 598M 524M 483M 452M 848M 56.4B 866M 5.81B 2.25B 27.88B 2.25B 2.2B 96.66B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.41% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -5.76% | ||
| 1 week | -0.20% | ||
| Current month | -13.78% | ||
| 1 month | -15.78% | ||
| 3 months | -18.88% | ||
| 6 months | -34.41% | ||
| Current year | -31.21% |
| 1 week | 4.81 |  | 6.09 |
| 1 month | 4.81 | | 6.09 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 23/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 10/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-04 | Buy | Director | 100 | 0.0000% | ||
| 28/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 27/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.76% | -0.20% | -28.79% | -48.48% | 813M | |
| +7.14% | +9.04% | +51.14% | +165.42% | 1,006B | |
| +3.82% | +9.63% | +66.80% | +54.96% | 589B | |
| +1.22% | +6.61% | +31.28% | +81.70% | 430B | |
| -0.66% | +5.11% | +29.26% | +21.27% | 331B | |
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | |
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | |
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | |
| +0.84% | +3.13% | +27.37% | +58.20% | 190B | |
| +1.46% | +0.55% | +16.67% | +64.01% | 154B | |
| Average | +0.98% | +5.42% | +24.02% | +42.50% | 348.66B | |
| Weighted average by Cap. | +3.04% | +5.38% | +39.27% | +78.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.08M 85.12M 78.46M 73.46M 138M 9.16B 141M 943M 365M 4.53B 365M 357M 15.69B | 624M 91.68M 80.38M 74.1M 69.37M 130M 8.65B 133M 891M 345M 4.27B 344M 337M 14.82B |
| Net income | -74.07M -10.89M -9.55M -8.8M -8.24M -15.45M -1.03B -15.77M -106M -40.93M -508M -40.88M -39.99M -1.76B | -347M -51.04M -44.75M -41.25M -38.62M -72.42M -4.81B -73.92M -496M -192M -2.38B -192M -187M -8.25B |
| Net Debt | -1.98B -291M -256M -236M -220M -413M -27.49B -422M -2.83B -1.1B -13.59B -1.09B -1.07B -47.11B | -1.14B -168M -147M -136M -127M -238M -15.83B -243M -1.63B -631M -7.82B -630M -616M -27.12B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | CN¥5.070 | -5.76% | 37,851,050 |
| 25/06/26 | CN¥5.380 | -7.24% | 61,914,867 |
| 24/06/26 | CN¥5.800 | +4.69% | 92,016,460 |
| 23/06/26 | CN¥5.540 | +9.92% | 27,344,111 |
| 22/06/26 | CN¥5.040 | -0.79% | 22,848,443 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
